Assessing the feasibility, acceptability, and implementation strategies for novel TB vaccines among adolescents and adults in Nigeria

VALIDATE Directors' Fund Project - June 2025 to June 2026

Led by:
Mr Oluwaseun Taofeek; VALIDATE Affiliate; Helix Biogen Institute, Nigeria
 

Project Aims

This project will assess the feasibility and acceptability of introducing novel tuberculosis vaccines (M72/AS01E and BCG revaccination) among adolescents and adults in Nigeria, and identify implementation strategies, barriers, and enablers to inform national TB vaccine rollout. The study will employ a qualitative descriptive design using semi-structured in-depth interviews with key expert stakeholders, purposively selected based on expertise in TB, vaccines, policy, and delivery, and representing civil society organizations (CSO), academia, government, and NGOs.